NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Stereotactic breast biopsy: comparison of histologic underestimation rates with 11- and 9-gauge vacuum-assisted breast biopsy.

Author(s): Lourenco AP, Mainiero MB, Lazarus E, Giri D, Schepps B

Publication: AJR Am J Roentgenol, 2007, Vol. 189, Page W275-9

PubMed ID: 17954625 PubMed Review Paper? No

Purpose of Paper

This paper compared the characteristics and underestimation rate of stereotactic vacuum-assisted breast biopsies obtained with 11- and 9-gauge needles.

Conclusion of Paper

The 11-gauge and 9-gauge biopsies had comparable rates of clusters of calcification. A comparable percentage of cases biopsied with the two needle types were upgraded from atypical ductal hyperplasia (ADH) to ductal carcinoma in situ (DCIS) or invasive carcinoma after surgical resection (28.3% and 29.6%, respectively) and from DCIS to invasive carcinoma after surgical resection (28.7% and 22.7%, respectively). In cases of DCIS, the rate of underestimation as ADH increased with increasing lesion size (odds ratio=1.039, P=0.03).

Studies

  1. Study Purpose

    This study compared the characteristics and underestimation rate of stereotactic vacuum-assisted breast biopsies obtained with 11- and 9-gauge needles. Results from stereotactic vacuum-assisted breast biopsies obtained with an 11-gauge needle in 828 cases and with a 9-gauge needle in 395 cases were compared with those obtained by surgical resection (239 cases). All lesions were BI-RADS category 4 or 5 and lesion size was comparable between groups. It is assumed that the pathological analysis included light microscopy and H&E staining of formalin-fixed paraffin-embedded sections.

     

    Summary of Findings:

    The 11-gauge and 9-gauge biopsies had comparable rates of clusters of calcification (82% and 87%, respectively) and non-calcified lesions including masses, architectural distortion, and asymmetries (18% and 13%, respectively). Slightly, but not significantly, more specimens per lesion were obtained with an 11-gauge needle (mean of 8 specimens, range 6-24) than with a 9-gauge needle (mean of 7 specimens, range 1-20). Comparable percentages of specimens diagnosed as ADH based on biopsy with an 11- or 9-gauge needle were found to contain DCIS or invasive carcinoma after surgical resection (28.3% and 29.6%, respectively P=0.9). Similarly, surgical specimens from cases diagnosed as DCIS in the biopsy were found to contain invasive carcinoma in 28.7% of cases (35 of 122) biopsied with an 11- gauge needle and 22.7% of cases (10 of 44) biopsied with a 9-gauge needle (P=0.4). Interestingly, in cases of DCIS the rate of underestimation as ADH increased with increasing lesion size (odds ratio=1.039, P=0.03).

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Benign
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Morphology H-and-E microscopy
    Morphology Light microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Acquisition Method of tissue acquisition Vacuum assisted biopsy
    Surgical resection
    Biospecimen Acquisition Needle gauge 11-gauge
    9-gauge

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...